Biology Direct

Papers
(The H4-Index of Biology Direct is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Identifying the driver miRNAs with somatic copy number alterations driving dysregulated ceRNA networks in cancers56
The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors44
Bcl-B: an “unknown” protein of the Bcl-2 family43
Alpha-actnin-4 (ACTN4) selectively affects the DNA double-strand breaks repair in non-small lung carcinoma cells43
Exploring the role of GhN/AINV23: implications for plant growth, development, and drought tolerance34
PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration32
Evolution of retrocopies in the context of HUSH silencing32
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells29
Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia29
Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma25
Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection25
Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway24
Mammalian enabled protein enhances tamoxifen sensitivity of the hormone receptor-positive breast cancer patients by suppressing the AKT signaling pathway23
Differential adaptive RNA editing signals between insects and plants revealed by a new measurement termed haplotype diversity20
Long-term longitudinal study on swine VML model20
Deciphering the impact of MreB on the morphology and pathogenicity of the aquatic pathogen Spiroplasma eriocheiris19
Inhibition of TRAF6 improves hyperlipidemic acute pancreatitis by alleviating pyroptosis in vitro and in vivo rat models18
Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease18
0.092848062515259